BIAGINI, AGNESE
 Distribuzione geografica
Continente #
EU - Europa 1.087
NA - Nord America 1.055
AS - Asia 258
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.451
Nazione #
US - Stati Uniti d'America 1.028
DE - Germania 585
SE - Svezia 163
CN - Cina 145
GB - Regno Unito 122
IT - Italia 73
BG - Bulgaria 57
SG - Singapore 42
CI - Costa d'Avorio 35
CA - Canada 27
AT - Austria 24
IN - India 21
TR - Turchia 20
RU - Federazione Russa 19
FI - Finlandia 16
SN - Senegal 15
VN - Vietnam 15
BE - Belgio 10
NL - Olanda 5
UA - Ucraina 5
FR - Francia 3
HK - Hong Kong 3
IR - Iran 3
AZ - Azerbaigian 2
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.451
Città #
Chandler 108
Woodbridge 100
Fairfield 97
Ann Arbor 92
Ashburn 84
Sofia 57
Beijing 50
New York 41
Wilmington 40
Houston 39
Abidjan 35
London 35
Seattle 35
Cambridge 34
Princeton 25
Boulder 23
Ottawa 23
Boardman 22
Vienna 22
Bremen 21
Des Moines 20
Lawrence 20
Medford 18
Dearborn 17
Singapore 16
Dakar 15
Florence 15
Serra 13
Los Angeles 12
Nanjing 11
Nürnberg 11
Brussels 10
Istanbul 10
Izmir 10
Frankfurt am Main 9
Shanghai 9
Changsha 8
Philadelphia 8
Dong Ket 6
Jiaxing 6
Lancaster 6
Munich 6
Wuhan 6
City of Westminster 4
Fuzhou 4
Guangzhou 4
Nanchang 4
Pisa 4
Quanzhou 4
San Diego 4
Bengaluru 3
Boydton 3
Chengdu 3
Düsseldorf 3
Hangzhou 3
Jacksonville 3
Ningbo 3
Ogden 3
Palermo 3
Pune 3
Washington 3
Baotou 2
Buffalo 2
Canary Wharf 2
Dallas 2
Hong Kong 2
Kunming 2
Nutley 2
Redmond 2
Redwood City 2
Sacile 2
Schiphol 2
Siena 2
Tappahannock 2
Tianjin 2
Auburn Hills 1
Beauharnois 1
Bratislava 1
Chelmsford 1
Cheyenne 1
Chicago 1
Copenhagen 1
Council Bluffs 1
Crawley 1
Delhi 1
Grafing 1
Groningen 1
Hebei 1
Hefei 1
Hejin 1
Indiana 1
Jinan 1
Kent 1
Lanzhou 1
Manila 1
Maruthayur 1
Naples 1
Norwalk 1
Pantai 1
Quzhou 1
Totale 1.359
Nome #
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 261
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 163
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE 151
null 146
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 145
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 144
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 136
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 127
Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico. 127
Il carcinoma tiroideo: nuove prospettive terapeutiche. 122
null 107
null 105
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) 87
null 84
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience 83
Significato prognostico della mutazione di BRAF in pazienti affetti da carcinoma papillare della tiroide con follow-up di 20 anni. 81
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) 75
Short term follow-up outcome of stage I thyroid cancer patients is worst when BRAFV600E mutation is present in the primary tumor. 72
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. 67
. Utilità della ricerca della mutazione di BRAF nel tumore primitivo di pazienti affetti da carcinoma papillare della tiroide a basso rischio. 46
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study 41
Il carcinoma della tiroide 36
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. 32
Ret Oncogene and Thyroid Carcinoma 24
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level. 22
Totale 2.484
Categoria #
all - tutte 6.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020352 0 0 0 0 43 59 52 26 31 57 78 6
2020/2021114 19 8 19 1 4 3 13 9 6 9 4 19
2021/2022266 10 10 2 26 59 33 11 7 13 9 13 73
2022/2023440 59 77 38 35 34 42 8 29 82 1 31 4
2023/2024175 16 11 15 0 21 46 18 6 3 9 9 21
2024/2025113 17 34 17 45 0 0 0 0 0 0 0 0
Totale 2.484